FLT3 and acute myeloid leukemia: A prevalent subgroup is characterized by mutations in signaling genes, notably activating mutations of tyrosine kinases (TKs) such as Fms‐like tyrosine kinase 3 (FLT3), found in approximately 30%–40% of AML cases [4].